Here's how NATURE.COM makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

NATURE . COM {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Nature.com Make Money
  6. How Much Does Nature.com Make
  7. Keywords
  8. Topics
  9. Questions
  10. Schema
  11. Social Networks
  12. External Links
  13. Analytics And Tracking
  14. Libraries
  15. Hosting Providers
  16. CDN Services

We are analyzing https://www.nature.com/articles/s41467-017-00263-7.

Title:
Systems analysis of apoptotic priming in ovarian cancer identifies vulnerabilities and predictors of drug response | Nature Communications
Description:
The lack of effective chemotherapies for high-grade serous ovarian cancers (HGS-OvCa) has motivated a search for alternative treatment strategies. Here, we present an unbiased systems-approach to interrogate a panel of 14 well-annotated HGS-OvCa patient-derived xenografts for sensitivity to PI3K and PI3K/mTOR inhibitors and uncover cell death vulnerabilities. Proteomic analysis reveals that PI3K/mTOR inhibition in HGS-OvCa patient-derived xenografts induces both pro-apoptotic and anti-apoptotic signaling responses that limit cell killing, but also primes cells for inhibitors of anti-apoptotic proteins. In-depth quantitative analysis of BCL-2 family proteins and other apoptotic regulators, together with computational modeling and selective anti-apoptotic protein inhibitors, uncovers new mechanistic details about apoptotic regulators that are predictive of drug sensitivity (BIM, caspase-3, BCL-XL) and resistance (MCL-1, XIAP). Our systems-approach presents a strategy for systematic analysis of the mechanisms that limit effective tumor cell killing and the identification of apoptotic vulnerabilities to overcome drug resistance in ovarian and other cancers. High-grade serous ovarian cancers (HGS-OvCa) frequently develop chemotherapy resistance. Here, the authors through a systematic analysis of proteomic and drug response data of 14 HGS-OvCa PDXs demonstrate that targeting apoptosis regulators can improve response of these tumors to inhibitors of the PI3K/mTOR pathway.
Website Age:
30 years and 10 months (reg. 1994-08-11).

Matching Content Categories {πŸ“š}

  • Science
  • Health & Fitness
  • Education

Content Management System {πŸ“}

What CMS is nature.com built with?

Custom-built

No common CMS systems were detected on Nature.com, and no known web development framework was identified.

Traffic Estimate {πŸ“ˆ}

What is the average monthly size of nature.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Nature.com Make Money? {πŸ’Έ}


Display Ads {🎯}


The website utilizes display ads within its content to generate revenue. Check the next section for further revenue estimates.

Ads are managed by yourbow.com. Particular relationships are as follows:

Direct Advertisers (10)
google.com, pmc.com, doceree.com, yourbow.com, audienciad.com, onlinemediasolutions.com, advibe.media, aps.amazon.com, getmediamx.com, onomagic.com

Reseller Advertisers (38)
conversantmedia.com, rubiconproject.com, pubmatic.com, appnexus.com, openx.com, smartadserver.com, lijit.com, sharethrough.com, video.unrulymedia.com, google.com, yahoo.com, triplelift.com, onetag.com, sonobi.com, contextweb.com, 33across.com, indexexchange.com, media.net, themediagrid.com, adform.com, richaudience.com, sovrn.com, improvedigital.com, freewheel.tv, smaato.com, yieldmo.com, amxrtb.com, adyoulike.com, adpone.com, criteo.com, smilewanted.com, 152media.info, e-planning.net, smartyads.com, loopme.com, opera.com, mediafuse.com, betweendigital.com

How Much Does Nature.com Make? {πŸ’°}


Display Ads {🎯}

$63,100 per month
Our estimates place Nature.com's monthly online earnings from display ads at $42,042 to $115,616.

Keywords {πŸ”}

cancer, fig, pdx, models, pubmed, combination, drug, cell, ovarian, article, gne, supplementary, inhibition, treatment, google, scholar, pikmtor, abt, protein, proteins, inhibitor, pathway, cas, analysis, mcl, levels, tumor, sensitivity, cells, inhibitors, death, data, central, response, bim, apoptotic, antiapoptotic, values, resistance, experiments, nature, bcl, bclbclxl, hgsovca, xiap, bclxl, vitro, effects, gdc, pik,

Topics {βœ’οΈ}

nature portfolio scientific editing privacy policy dual pan-pi3-kinase/mtor inhibitors advertising combination index pi3k/akt/mtor pathway activation15 pi3k-Ξ±/Ξ³/Ξ΄ inhibitor phosphoinositide 3-kinase/akt/mammalian target social media pi3k/akt/mtor pathway activation nature nature 474 nature 527 ovarian cancer research reprints pulsed bcl-2/bcl-xl inhibitor selective pi3k/akt/mtor inhibitors pi3k/akt/mtor pathway targets bcl-2/bcl-xl inhibition enhances bcl-xl-specific inhibitor combinations bcl-2/bcl-xl inhibitor combination translational cancer research applied cancer research bcl-2/bcl-xl drug combination pi3k/mtor-based combination therapies high bcl-xl levels anti-apoptotic proteins bcl-xl targeted therapy development dual pi3k/mtor inhibitor bcl-2/bcl-xl combination treatment dual pi3k/mtor inhibition fibroblast-related prognostic signature phospho-4ebp1 protein levels matrix-attached cancer cells cancer genome atlas bcl-xl protein levels patient-derived cancer cells author information authors pi3k/akt/mtor axis pi3k/akt/mtor pathway ras/erk pathway activity pan-pi3k inhibitor pictilisib phosphoinositide-3-kinase antagonist aezs-126 phospho-akts473 protein levels pi3k/mtor-inhibition induces real-time therapy tailoring iccb-longwood screening facility pi3k/akt activation status single-cell expression profiles

Questions {❓}

  • Cancer Systems Biology: a peek into the future of patient care?
  • Potential of apoptotic pathway-targeted cancer therapeutic research: Where do we stand?

Schema {πŸ—ΊοΈ}

WebPage:
      mainEntity:
         headline:Systems analysis of apoptotic priming in ovarian cancer identifies vulnerabilities and predictors of drug response
         description:The lack of effective chemotherapies for high-grade serous ovarian cancers (HGS-OvCa) has motivated a search for alternative treatment strategies. Here, we present an unbiased systems-approach to interrogate a panel of 14 well-annotated HGS-OvCa patient-derived xenografts for sensitivity to PI3K and PI3K/mTOR inhibitors and uncover cell death vulnerabilities. Proteomic analysis reveals that PI3K/mTOR inhibition in HGS-OvCa patient-derived xenografts induces both pro-apoptotic and anti-apoptotic signaling responses that limit cell killing, but also primes cells for inhibitors of anti-apoptotic proteins. In-depth quantitative analysis of BCL-2 family proteins and other apoptotic regulators, together with computational modeling and selective anti-apoptotic protein inhibitors, uncovers new mechanistic details about apoptotic regulators that are predictive of drug sensitivity (BIM, caspase-3, BCL-XL) and resistance (MCL-1, XIAP). Our systems-approach presents a strategy for systematic analysis of the mechanisms that limit effective tumor cell killing and the identification of apoptotic vulnerabilities to overcome drug resistance in ovarian and other cancers. High-grade serous ovarian cancers (HGS-OvCa) frequently develop chemotherapy resistance. Here, the authors through a systematic analysis of proteomic and drug response data of 14 HGS-OvCa PDXs demonstrate that targeting apoptosis regulators can improve response of these tumors to inhibitors of the PI3K/mTOR pathway.
         datePublished:2017-08-28T00:00:00Z
         dateModified:2017-08-28T00:00:00Z
         pageStart:1
         pageEnd:13
         license:http://creativecommons.org/licenses/by/4.0/
         sameAs:https://doi.org/10.1038/s41467-017-00263-7
         keywords:
            Apoptosis
            Cancer therapeutic resistance
            Ovarian cancer
            Systems analysis
            Tumour biomarkers
            Science
            Humanities and Social Sciences
            multidisciplinary
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41467-017-00263-7/MediaObjects/41467_2017_263_Fig1_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41467-017-00263-7/MediaObjects/41467_2017_263_Fig2_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41467-017-00263-7/MediaObjects/41467_2017_263_Fig3_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41467-017-00263-7/MediaObjects/41467_2017_263_Fig4_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41467-017-00263-7/MediaObjects/41467_2017_263_Fig5_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41467-017-00263-7/MediaObjects/41467_2017_263_Fig6_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41467-017-00263-7/MediaObjects/41467_2017_263_Fig7_HTML.jpg
         isPartOf:
            name:Nature Communications
            issn:
               2041-1723
            volumeNumber:8
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Nature Publishing Group UK
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Ioannis K. Zervantonakis
               url:http://orcid.org/0000-0003-2386-9553
               affiliation:
                     name:Ludwig Center at Harvard, Harvard Medical School
                     address:
                        name:Department of Cell Biology, Ludwig Center at Harvard, Harvard Medical School, Boston, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Claudia Iavarone
               affiliation:
                     name:Ludwig Center at Harvard, Harvard Medical School
                     address:
                        name:Department of Cell Biology, Ludwig Center at Harvard, Harvard Medical School, Boston, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Hsing-Yu Chen
               affiliation:
                     name:Ludwig Center at Harvard, Harvard Medical School
                     address:
                        name:Department of Cell Biology, Ludwig Center at Harvard, Harvard Medical School, Boston, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Laura M. Selfors
               affiliation:
                     name:Ludwig Center at Harvard, Harvard Medical School
                     address:
                        name:Department of Cell Biology, Ludwig Center at Harvard, Harvard Medical School, Boston, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Sangeetha Palakurthi
               affiliation:
                     name:Dana Farber Cancer Institute
                     address:
                        name:Belfer Center for Applied Cancer Research, Dana Farber Cancer Institute, Boston, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Joyce F. Liu
               affiliation:
                     name:Dana Farber Cancer Institute
                     address:
                        name:Department of Medical Oncology, Dana Farber Cancer Institute, Boston, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Ronny Drapkin
               url:http://orcid.org/0000-0002-6912-6977
               affiliation:
                     name:University of Pennsylvania School of Medicine
                     address:
                        name:Penn Ovarian Cancer Research Center, Department of Obstetrics and Gynecology, University of Pennsylvania School of Medicine, Philadelphia, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Ursula Matulonis
               affiliation:
                     name:Dana Farber Cancer Institute
                     address:
                        name:Department of Medical Oncology, Dana Farber Cancer Institute, Boston, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Joel D. Leverson
               affiliation:
                     name:Oncology Development, AbbVie, Inc
                     address:
                        name:Oncology Development, AbbVie, Inc, North Chicago, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Deepak Sampath
               affiliation:
                     name:Translational Oncology, Genentech
                     address:
                        name:Translational Oncology, Genentech, South San Francisco, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Gordon B. Mills
               affiliation:
                     name:MD Anderson Cancer Center
                     address:
                        name:Department of Systems Biology, MD Anderson Cancer Center, Houston, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Joan S. Brugge
               affiliation:
                     name:Ludwig Center at Harvard, Harvard Medical School
                     address:
                        name:Department of Cell Biology, Ludwig Center at Harvard, Harvard Medical School, Boston, USA
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:1
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Systems analysis of apoptotic priming in ovarian cancer identifies vulnerabilities and predictors of drug response
      description:The lack of effective chemotherapies for high-grade serous ovarian cancers (HGS-OvCa) has motivated a search for alternative treatment strategies. Here, we present an unbiased systems-approach to interrogate a panel of 14 well-annotated HGS-OvCa patient-derived xenografts for sensitivity to PI3K and PI3K/mTOR inhibitors and uncover cell death vulnerabilities. Proteomic analysis reveals that PI3K/mTOR inhibition in HGS-OvCa patient-derived xenografts induces both pro-apoptotic and anti-apoptotic signaling responses that limit cell killing, but also primes cells for inhibitors of anti-apoptotic proteins. In-depth quantitative analysis of BCL-2 family proteins and other apoptotic regulators, together with computational modeling and selective anti-apoptotic protein inhibitors, uncovers new mechanistic details about apoptotic regulators that are predictive of drug sensitivity (BIM, caspase-3, BCL-XL) and resistance (MCL-1, XIAP). Our systems-approach presents a strategy for systematic analysis of the mechanisms that limit effective tumor cell killing and the identification of apoptotic vulnerabilities to overcome drug resistance in ovarian and other cancers. High-grade serous ovarian cancers (HGS-OvCa) frequently develop chemotherapy resistance. Here, the authors through a systematic analysis of proteomic and drug response data of 14 HGS-OvCa PDXs demonstrate that targeting apoptosis regulators can improve response of these tumors to inhibitors of the PI3K/mTOR pathway.
      datePublished:2017-08-28T00:00:00Z
      dateModified:2017-08-28T00:00:00Z
      pageStart:1
      pageEnd:13
      license:http://creativecommons.org/licenses/by/4.0/
      sameAs:https://doi.org/10.1038/s41467-017-00263-7
      keywords:
         Apoptosis
         Cancer therapeutic resistance
         Ovarian cancer
         Systems analysis
         Tumour biomarkers
         Science
         Humanities and Social Sciences
         multidisciplinary
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41467-017-00263-7/MediaObjects/41467_2017_263_Fig1_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41467-017-00263-7/MediaObjects/41467_2017_263_Fig2_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41467-017-00263-7/MediaObjects/41467_2017_263_Fig3_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41467-017-00263-7/MediaObjects/41467_2017_263_Fig4_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41467-017-00263-7/MediaObjects/41467_2017_263_Fig5_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41467-017-00263-7/MediaObjects/41467_2017_263_Fig6_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41467-017-00263-7/MediaObjects/41467_2017_263_Fig7_HTML.jpg
      isPartOf:
         name:Nature Communications
         issn:
            2041-1723
         volumeNumber:8
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Nature Publishing Group UK
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Ioannis K. Zervantonakis
            url:http://orcid.org/0000-0003-2386-9553
            affiliation:
                  name:Ludwig Center at Harvard, Harvard Medical School
                  address:
                     name:Department of Cell Biology, Ludwig Center at Harvard, Harvard Medical School, Boston, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Claudia Iavarone
            affiliation:
                  name:Ludwig Center at Harvard, Harvard Medical School
                  address:
                     name:Department of Cell Biology, Ludwig Center at Harvard, Harvard Medical School, Boston, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Hsing-Yu Chen
            affiliation:
                  name:Ludwig Center at Harvard, Harvard Medical School
                  address:
                     name:Department of Cell Biology, Ludwig Center at Harvard, Harvard Medical School, Boston, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Laura M. Selfors
            affiliation:
                  name:Ludwig Center at Harvard, Harvard Medical School
                  address:
                     name:Department of Cell Biology, Ludwig Center at Harvard, Harvard Medical School, Boston, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Sangeetha Palakurthi
            affiliation:
                  name:Dana Farber Cancer Institute
                  address:
                     name:Belfer Center for Applied Cancer Research, Dana Farber Cancer Institute, Boston, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Joyce F. Liu
            affiliation:
                  name:Dana Farber Cancer Institute
                  address:
                     name:Department of Medical Oncology, Dana Farber Cancer Institute, Boston, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Ronny Drapkin
            url:http://orcid.org/0000-0002-6912-6977
            affiliation:
                  name:University of Pennsylvania School of Medicine
                  address:
                     name:Penn Ovarian Cancer Research Center, Department of Obstetrics and Gynecology, University of Pennsylvania School of Medicine, Philadelphia, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Ursula Matulonis
            affiliation:
                  name:Dana Farber Cancer Institute
                  address:
                     name:Department of Medical Oncology, Dana Farber Cancer Institute, Boston, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Joel D. Leverson
            affiliation:
                  name:Oncology Development, AbbVie, Inc
                  address:
                     name:Oncology Development, AbbVie, Inc, North Chicago, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Deepak Sampath
            affiliation:
                  name:Translational Oncology, Genentech
                  address:
                     name:Translational Oncology, Genentech, South San Francisco, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Gordon B. Mills
            affiliation:
                  name:MD Anderson Cancer Center
                  address:
                     name:Department of Systems Biology, MD Anderson Cancer Center, Houston, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Joan S. Brugge
            affiliation:
                  name:Ludwig Center at Harvard, Harvard Medical School
                  address:
                     name:Department of Cell Biology, Ludwig Center at Harvard, Harvard Medical School, Boston, USA
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:1
["Periodical","PublicationVolume"]:
      name:Nature Communications
      issn:
         2041-1723
      volumeNumber:8
Organization:
      name:Nature Publishing Group UK
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Ludwig Center at Harvard, Harvard Medical School
      address:
         name:Department of Cell Biology, Ludwig Center at Harvard, Harvard Medical School, Boston, USA
         type:PostalAddress
      name:Ludwig Center at Harvard, Harvard Medical School
      address:
         name:Department of Cell Biology, Ludwig Center at Harvard, Harvard Medical School, Boston, USA
         type:PostalAddress
      name:Ludwig Center at Harvard, Harvard Medical School
      address:
         name:Department of Cell Biology, Ludwig Center at Harvard, Harvard Medical School, Boston, USA
         type:PostalAddress
      name:Ludwig Center at Harvard, Harvard Medical School
      address:
         name:Department of Cell Biology, Ludwig Center at Harvard, Harvard Medical School, Boston, USA
         type:PostalAddress
      name:Dana Farber Cancer Institute
      address:
         name:Belfer Center for Applied Cancer Research, Dana Farber Cancer Institute, Boston, USA
         type:PostalAddress
      name:Dana Farber Cancer Institute
      address:
         name:Department of Medical Oncology, Dana Farber Cancer Institute, Boston, USA
         type:PostalAddress
      name:University of Pennsylvania School of Medicine
      address:
         name:Penn Ovarian Cancer Research Center, Department of Obstetrics and Gynecology, University of Pennsylvania School of Medicine, Philadelphia, USA
         type:PostalAddress
      name:Dana Farber Cancer Institute
      address:
         name:Department of Medical Oncology, Dana Farber Cancer Institute, Boston, USA
         type:PostalAddress
      name:Oncology Development, AbbVie, Inc
      address:
         name:Oncology Development, AbbVie, Inc, North Chicago, USA
         type:PostalAddress
      name:Translational Oncology, Genentech
      address:
         name:Translational Oncology, Genentech, South San Francisco, USA
         type:PostalAddress
      name:MD Anderson Cancer Center
      address:
         name:Department of Systems Biology, MD Anderson Cancer Center, Houston, USA
         type:PostalAddress
      name:Ludwig Center at Harvard, Harvard Medical School
      address:
         name:Department of Cell Biology, Ludwig Center at Harvard, Harvard Medical School, Boston, USA
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Ioannis K. Zervantonakis
      url:http://orcid.org/0000-0003-2386-9553
      affiliation:
            name:Ludwig Center at Harvard, Harvard Medical School
            address:
               name:Department of Cell Biology, Ludwig Center at Harvard, Harvard Medical School, Boston, USA
               type:PostalAddress
            type:Organization
      name:Claudia Iavarone
      affiliation:
            name:Ludwig Center at Harvard, Harvard Medical School
            address:
               name:Department of Cell Biology, Ludwig Center at Harvard, Harvard Medical School, Boston, USA
               type:PostalAddress
            type:Organization
      name:Hsing-Yu Chen
      affiliation:
            name:Ludwig Center at Harvard, Harvard Medical School
            address:
               name:Department of Cell Biology, Ludwig Center at Harvard, Harvard Medical School, Boston, USA
               type:PostalAddress
            type:Organization
      name:Laura M. Selfors
      affiliation:
            name:Ludwig Center at Harvard, Harvard Medical School
            address:
               name:Department of Cell Biology, Ludwig Center at Harvard, Harvard Medical School, Boston, USA
               type:PostalAddress
            type:Organization
      name:Sangeetha Palakurthi
      affiliation:
            name:Dana Farber Cancer Institute
            address:
               name:Belfer Center for Applied Cancer Research, Dana Farber Cancer Institute, Boston, USA
               type:PostalAddress
            type:Organization
      name:Joyce F. Liu
      affiliation:
            name:Dana Farber Cancer Institute
            address:
               name:Department of Medical Oncology, Dana Farber Cancer Institute, Boston, USA
               type:PostalAddress
            type:Organization
      name:Ronny Drapkin
      url:http://orcid.org/0000-0002-6912-6977
      affiliation:
            name:University of Pennsylvania School of Medicine
            address:
               name:Penn Ovarian Cancer Research Center, Department of Obstetrics and Gynecology, University of Pennsylvania School of Medicine, Philadelphia, USA
               type:PostalAddress
            type:Organization
      name:Ursula Matulonis
      affiliation:
            name:Dana Farber Cancer Institute
            address:
               name:Department of Medical Oncology, Dana Farber Cancer Institute, Boston, USA
               type:PostalAddress
            type:Organization
      name:Joel D. Leverson
      affiliation:
            name:Oncology Development, AbbVie, Inc
            address:
               name:Oncology Development, AbbVie, Inc, North Chicago, USA
               type:PostalAddress
            type:Organization
      name:Deepak Sampath
      affiliation:
            name:Translational Oncology, Genentech
            address:
               name:Translational Oncology, Genentech, South San Francisco, USA
               type:PostalAddress
            type:Organization
      name:Gordon B. Mills
      affiliation:
            name:MD Anderson Cancer Center
            address:
               name:Department of Systems Biology, MD Anderson Cancer Center, Houston, USA
               type:PostalAddress
            type:Organization
      name:Joan S. Brugge
      affiliation:
            name:Ludwig Center at Harvard, Harvard Medical School
            address:
               name:Department of Cell Biology, Ludwig Center at Harvard, Harvard Medical School, Boston, USA
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Department of Cell Biology, Ludwig Center at Harvard, Harvard Medical School, Boston, USA
      name:Department of Cell Biology, Ludwig Center at Harvard, Harvard Medical School, Boston, USA
      name:Department of Cell Biology, Ludwig Center at Harvard, Harvard Medical School, Boston, USA
      name:Department of Cell Biology, Ludwig Center at Harvard, Harvard Medical School, Boston, USA
      name:Belfer Center for Applied Cancer Research, Dana Farber Cancer Institute, Boston, USA
      name:Department of Medical Oncology, Dana Farber Cancer Institute, Boston, USA
      name:Penn Ovarian Cancer Research Center, Department of Obstetrics and Gynecology, University of Pennsylvania School of Medicine, Philadelphia, USA
      name:Department of Medical Oncology, Dana Farber Cancer Institute, Boston, USA
      name:Oncology Development, AbbVie, Inc, North Chicago, USA
      name:Translational Oncology, Genentech, South San Francisco, USA
      name:Department of Systems Biology, MD Anderson Cancer Center, Houston, USA
      name:Department of Cell Biology, Ludwig Center at Harvard, Harvard Medical School, Boston, USA

External Links {πŸ”—}(245)

Analytics and Tracking {πŸ“Š}

  • Google Tag Manager

Libraries {πŸ“š}

  • Prism.js
  • Zoom.js

Emails and Hosting {βœ‰οΈ}

Mail Servers:

  • mxa-002c5801.gslb.pphosted.com
  • mxb-002c5801.gslb.pphosted.com

Name Servers:

  • pdns1.ultradns.net
  • pdns2.ultradns.net
  • pdns3.ultradns.org
  • pdns4.ultradns.org
  • pdns5.ultradns.info
  • pdns6.ultradns.co.uk

CDN Services {πŸ“¦}

  • Crossref

4.75s.